These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1723037)

  • 1. Genotype-treatment interaction between amantadine and chlorpromazine in the mouse.
    Messiha FS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(3):323-6. PubMed ID: 1723037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amantadine on motility of reserpinized mice as a function of brain biogenic amines and mouse strains.
    Messiha FS
    Brain Res Bull; 1989; 23(4-5):267-71. PubMed ID: 2590838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain.
    Messiha FS
    Neurotoxicology; 1991; 12(3):571-81. PubMed ID: 1745440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and genetic interrelationships between locomotor activity and brain biogenic amines.
    Messiha FS; Martin WJ; Bucher KD
    Gen Pharmacol; 1990; 21(4):459-64. PubMed ID: 1696231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a secondary and a tertiary amine tricyclic antidepressant on cerebral biogenic amines as a function of mouse strain: a comparative neurotoxicological evaluation.
    Messiha FS
    Toxicol Lett; 1991 Sep; 58(1):77-84. PubMed ID: 1716794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral genetic analysis of regional mouse brain biogenic amines, acidic metabolites and motor activity.
    Messiha FS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(2):389-92. PubMed ID: 1980448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion.
    Alfredsson G; Wiesel FA; Skett P
    Psychopharmacology (Berl); 1977 Jun; 53(1):13-8. PubMed ID: 407609
    [No Abstract]   [Full Text] [Related]  

  • 9. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on monoamine metabolism in three regions of mouse brain during pregnancy: monoamine metabolite concentrations and the effects of injected hormones.
    Greengrass PM; Tonge SR
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):48-59. PubMed ID: 4451418
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies on isolation-induced aggressiveness in mice in relation to biogenic amines.
    Roliński Z
    Pol J Pharmacol Pharm; 1975; 27(1):37-44. PubMed ID: 1167693
    [No Abstract]   [Full Text] [Related]  

  • 12. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of gonadectomy on monoamine metabolism in three regions of mouse brain.
    Greengrass PM; Tonge SR
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):46-52. PubMed ID: 125564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new eburnamine derivative, RU 24722, on the turnover of monoamines in mouse brain: selective and reversible decrease of noradrenaline.
    Takeda N; Yamatodani A; Watanabe T; Wada H
    Eur J Pharmacol; 1984 Nov; 106(2):357-62. PubMed ID: 6085052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC; Yates CM
    Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouse.
    Messiha FS
    Neurosci Biobehav Rev; 1988; 12(3-4):219-22. PubMed ID: 3226646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of bradykinin with dopaminergic receptors in the CNS.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1977; 29(3):301-11. PubMed ID: 887505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.